Raymond James Financial’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.91M Sell
105,242
-25,372
-19% -$2.53M ﹤0.01% 2032
2025
Q4
$12.9M Buy
130,614
+30,590
+31% +$2.96M ﹤0.01% 1768
2025
Q3
$8.48M Buy
100,024
+24,231
+32% +$1.92M ﹤0.01% 2058
2025
Q2
$5.16M Buy
75,793
+6,031
+9% +$382K ﹤0.01% 2363
2025
Q1
$4.22M Buy
69,762
+17,313
+33% +$1.21M ﹤0.01% 2447
2024
Q4
$3.62M Buy
+52,449
New +$3.74M ﹤0.01% 2542

Other funds holding INCY

Raymond James Financial's INCY Position: Q1 2026 in Review

Raymond James Financial reduced its Incyte (INCY) stake by 19% in Q1 2026, selling an estimated $2.53M and leaving 105,242 shares worth $9.91M. The position accounts for ﹤0.01% of the portfolio, ranked #2032.

Raymond James Financial first reported a position in INCY in Q4 2024 and has held it in 6 quarters since. The position peaked at $12.9M in Q4 2025. 810 funds tracked by Wall St. Rank hold INCY as of Q1 2026.

  • Raymond James Financial held 105,242 shares of Incyte worth $9.91M as of Q1 2026.
  • Raymond James Financial sold 25,372 Incyte shares in Q1 2026, an estimated $2.53M.
  • Incyte made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #2032 holding.
  • Raymond James Financial first reported a position in Incyte in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Incyte position peaked at $12.9M in Q4 2025.
  • 810 funds tracked by Wall St. Rank held Incyte as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.